Studies on substances of microbial origin which protect central nervous system
保护中枢神经系统的微生物来源物质的研究
基本信息
- 批准号:10660104
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In the course of our screening program for AMPA/kainate antagonists to treat brain ischemia injury known as stroke, we isolated a potent AMPA anatagonist designated kaitocephalin from a fungi identified to Eupenicillium shearii. This compound effectively protected rat hippocampal neurons from AMPA and kainate toxicity without showing cytotoxicity. Since the stereochemistry plays a significant role in the biological activities on glutamate receptor, we established the absolute stereochemistry of kaitocephalin as 2S3S4R7R9S by analyzing the NMR spectra such as NOEs applying to the chemically modified compounds.In the receptor binding assay for glutamate agonists, kaitocephalin showed potent binding activity to the agonist binding site of NMDA receptor. It also exhibited binding affinities AMPA receptor but showed slight binding activity on kainate receptor. In this way it has a high affinity to NMDA receptor, we investigated the protective effect of kaitocephalin against NMDA toxicity in … More rat hippocampal neurons. It effectively protected rat hippocampal neurons from neuronal damage induced by NMDA. To reveal the mode of action, we next studied the inhibitory effects of kaitocephalin on CaィイD12+ィエD1 influx induced by glutamate agonists. Kaitocephalin blocked CaィイD12+ィエD1 influx induced by AMPA but not by kainate in rat hippocampal neurons. This result is coincident to affinity binding experiments, but quite different from the hypothesis of CaィイD12+ィエD1 induced neurotoxicity. So that we employed rat hippocampal organotypic culture system using rat hippocampal slices in which the selective response to the different glutamate agonists could be observed. Kaitocephalin protected CA1 and CA3 regions from NMDA, AMPA and kainate. Kaitocephalin blocked CaィイD12+ィエD1 influx in CA1 and CA3 region elicited by NMDA and AMPA, respectively. To the contrary, kaitocephalin failed to block CaィイD12+ィエD1 influx mediated through kainate receptor. These results proved that CaィイD12+ィエD1 influx induced by glutamate agonists did not always attribute neuronal cell death. It is a quite important disovery in the central nervous physiology and also imply the novel hypothesis to the mechanism of neuronal cell death. Less
在我们筛选AMPA/kainate拮抗剂治疗脑缺血损伤(即中风)的过程中,我们从一种真菌中分离出一种有效的AMPA拮抗剂,命名为kaitocephalin。该化合物能有效保护大鼠海马神经元免受AMPA和海盐酸盐的毒性,而不显示细胞毒性。由于立体化学在谷氨酸受体的生物活性中起着重要的作用,我们通过分析化学修饰后的化合物的核磁共振谱(NOEs),确定了凯头脑苷的绝对立体化学为2S3S4R7R9S。在谷氨酸受体激动剂的受体结合实验中,kaiitocephalin对NMDA受体激动剂结合位点显示出强大的结合活性。对AMPA受体也表现出亲和力,但对盐酸盐受体的结合活性较弱。通过对NMDA受体的高亲和性,研究了凯头啡对NMDA毒性的保护作用。它能有效地保护大鼠海马神经元免受NMDA诱导的神经元损伤。为了揭示作用模式,我们进一步研究了凯头啡素对谷氨酸激动剂诱导的Ca γ γ - D12+ γ - D1内流的抑制作用。kaiitocephalin阻断AMPA诱导的大鼠海马神经元Ca γ γ γ - D12+ γ - D1内流,而非kainate诱导的。这一结果与亲和结合实验结果一致,但与Ca γ γ - D12+ γ - D1诱导神经毒性的假设有较大差异。因此,我们采用大鼠海马器官型培养系统,利用大鼠海马切片,观察对不同谷氨酸激动剂的选择性反应。Kaitocephalin保护CA1和CA3区域免受NMDA、AMPA和kainate的伤害。kaiitocephalin分别阻断NMDA和AMPA诱导的CA1和CA3区Ca γ γ - D12+ γ - D1内流。相反,kaiitocephalin未能阻断通过盐酸盐受体介导的Ca γ γ γ - D12+ γ - D1内流。这些结果证明谷氨酸激动剂诱导的Ca γ γ - D12+ γ - D1内流并不总是导致神经元细胞死亡。这是中枢神经生理学的一项重要发现,也为神经元细胞死亡机制提供了新的假说。少
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Noriyuki Yamashita, Kazuo Shin-ya, Kazuo Furihata, Yoichi Hayakawa and Haruo Seto: "New ravidomycin analogies, FE35A and FE35B, apoptosis inducers produced by Streptomyces rochei"Journal of Antibiotics. 51. 1105-1108 (1998)
Noriyuki Yamashita、Kazuo Shin-ya、Kazuo Furihata、Yoichi Hayakawa 和 Haruo Seto:“新拉维霉素类似物,FE35A 和 FE35B,由罗氏链霉菌产生的细胞凋亡诱导剂”抗生素杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Noriyuki Yamashita, et al.: "New ravidomycin analogues, FE35A and FE35B, apoptosis inducers produced by Streptomyces rochei"Journal of Antibiotics. 51. 1105-1108 (1998)
Noriyuki Yamashita 等:“新拉维霉素类似物,FE35A 和 FE35B,由罗氏链霉菌产生的细胞凋亡诱导剂”抗生素杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
新家一男、瀬戸治男: "生体物質相互作用のリアルタイム解析実験法(BIACOREを中心に)"シュプリンガー・フェアラーク東京株式会社. 268 (1998)
Kazuo Shinke、Haruo Seto:“生物材料相互作用实时分析的实验方法(以 BIACORE 为中心)” Springer-Verlag Tokyo Co., Ltd. 268 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Toshihiro Kunigami, Kazuo Shin-ya, Kazuo Furihata, Keiko Furihata, Yoichi Hayakawa and Haruo Seto: "A novel neuronal protecting substance, aestivophoenin C, produced by Streptomyces purpeofuscus"Journal of Antibiotics. 51. 880-882 (1998)
Toshihiro Kunigami、Kazuo Shin-ya、Kazuo Furihata、Keiko Furihata、Yoichi Hayakawa 和 Haruo Seto:“由紫褐链霉菌产生的一种新型神经元保护物质,aestivophoenin C”《抗生素杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nobuaki Tsuge et al.: "Novel antibiotics pyrisulfoxin A and B produced by Streptomyces salifurnicus"J. Antibiotics. 52. 505-507 (1999)
Nobuaki Tsuge 等:“Streptomyces salifurnicus 产生的新型抗生素pyrisulfoxin A 和 B”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIN-YA Kazuo其他文献
SHIN-YA Kazuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIN-YA Kazuo', 18)}}的其他基金
Studies on screening for substances which act on cancer stem cells established from tumors surgically excised from brain tumor patients.
研究筛选作用于从脑肿瘤患者手术切除的肿瘤中建立的癌症干细胞的物质。
- 批准号:
23380067 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on apoptosis regulators substances of microbial origin aiming at neuroprotection
微生物来源的凋亡调节物质的神经保护研究
- 批准号:
13660104 - 财政年份:2001
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
GPR4 in blood brain barrier dysfunction in brain ischemia
GPR4在脑缺血血脑屏障功能障碍中的作用
- 批准号:
10711110 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Change in NSF ATPase activity Leads to Brain Ischemia Reperfusion Injury
NSF ATP酶活性变化导致脑缺血再灌注损伤
- 批准号:
10748602 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
GPR4 in blood brain barrier dysfunction in brain ischemia
GPR4在脑缺血血脑屏障功能障碍中的作用
- 批准号:
10522141 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Novel anti-NPC aggregation strategy against brain ischemia-reperfusion injury
抗脑缺血再灌注损伤的新型抗NPC聚集策略
- 批准号:
10747258 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Metabolic origin of oxidative stress injury in brain ischemia/reperfusion
脑缺血/再灌注氧化应激损伤的代谢起源
- 批准号:
10354477 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
GPR4 in blood brain barrier dysfunction in brain ischemia
GPR4在脑缺血血脑屏障功能障碍中的作用
- 批准号:
10652655 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Metabolic Origin of Oxidative Stress Injury in Brain Ischemia/Reperfusion
脑缺血/再灌注氧化应激损伤的代谢起源
- 批准号:
10592282 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Association of brain temperature increase and cerebrospinal fluid dynamics in chronic brain ischemia due to main trunk occlusion of cerebral arteries
脑动脉主干闭塞所致慢性脑缺血脑温度升高与脑脊液动力学的关系
- 批准号:
21K09108 - 财政年份:2021
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neuroprotective role of OGR1 in brain ischemia
OGR1在脑缺血中的神经保护作用
- 批准号:
10505248 - 财政年份:2021
- 资助金额:
$ 2.18万 - 项目类别:
Novel Ultrasound Indices of Intracranial Pressure and Brain Ischemia in Neonatal Hydrocephalus
新生儿脑积水颅内压和脑缺血的新型超声指标
- 批准号:
10455577 - 财政年份:2020
- 资助金额:
$ 2.18万 - 项目类别:














{{item.name}}会员




